N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.
N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.
复制标题
DOI:
10.1016/j.ymgme.2018.02.013
复制
发表时间:
2018-04
影响因子:
3.8
通讯作者:
Falk MJ
中科院分区:
文献类型:
--
作者:
Polyak E;Ostrovsky J;Peng M;Dingley SD;Tsukikawa M;Kwon YJ;McCormack SE;Bennett M;Xiao R;Seiler C;Zhang Z;Falk MJ
Oxidative stress is a known contributing factor in mitochondrial respiratory chain (RC) disease pathogenesis. Yet, no efficient means exists to objectively evaluate the comparative therapeutic efficacy or toxicity of different antioxidant compounds empirically used in human RC disease. We postulated that the pre-clinical comparative analysis of diverse antioxidant drugs having suggested utility in primary RC disease using animal and cellular models of RC dysfunction may improve understanding of their integrated effects and physiologic mechanisms, and enable prioritization of lead antioxidant molecules to pursue in human clinical trials. Here, lifespan effects of N-acetylcysteine (NAC), vitamin E, vitamin C, coenzyme Q10 (CoQ10), mitochondrial-targeted CoQ10 (MS010), lipoate, and orotate were evaluated as the primary outcome in a well-established, short-lived C. elegans gas-1(fc21) model of RC complex I disease. Healthspan effects were interrogated to assess potential reversal of their globally disrupted in vivo mitochondrial physiology, transcriptome profiles, and intermediary metabolic flux. NAC, vitamin E, and partially coenzyme Q rescued gas-1(fc21) lifespan toward that of wild-type N2 Bristol worms. MS010 and CoQ10 largely reversed biochemical pathway expression changes in gas-1(fc21) worms. While nearly all drugs normalized the upregulated expression of the ‘cellular antioxidant pathway’, they failed to rescue the mutant worms’ increased in vivo mitochondrial oxidant burden. NAC and vitamin E therapeutic efficacy were validated in human fibroblast and/or zebrafish complex I disease models. Remarkably, rotenone-induced zebrafish brain death was preventable partially with NAC and fully with vitamin E. Overall, these preclinical model animal data demonstrate that several classical antioxidant drugs do yield significant benefit on viability and survival in primary mitochondrial disease, where their major therapeutic benefit appears to result from targeting global cellular, rather than intramitochondria-specific, oxidative stress. Clinical trials are needed to evaluate whether the two antioxidants, NAC and vitamin E, that show greatest efficacy in translational model animals significantly improve the survival, function, and feeling of human subjects with primary mitochondrial RC disease.
登录
查看更多内容
影响因子:
3.9
作者:
Douiev L;Soiferman D;Alban C;Saada A
通讯作者:
Saada A
影响因子:
9.8
作者:
Gai, Xiaowu;Ghezzi, Daniele;Zeviani, Massimo
通讯作者:
Zeviani, Massimo
影响因子:
3.7
作者:
Abadi A;Crane JD;Ogborn D;Hettinga B;Akhtar M;Stokl A;Macneil L;Safdar A;Tarnopolsky M
通讯作者:
Tarnopolsky M
DOI:
10.1007/978-1-61779-504-6_16
发表时间:
2012
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
Dingley, Stephen;Chapman, Kimberly A;Falk, Marni J
通讯作者:
Falk, Marni J
影响因子:
4.3
作者:
Dale, K.;Rasinger, J. D.;Ellingsen, S.
通讯作者:
Ellingsen, S.